vigabatrin has been researched along with Parkinson Disease, Secondary in 2 studies
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Korsgaard, S | 1 |
| Casey, DE | 1 |
| Gerlach, J | 1 |
| Danion, JM | 1 |
| Singer, L | 1 |
| Tell, G | 1 |
| Schechter, P | 1 |
1 trial available for vigabatrin and Parkinson Disease, Secondary
| Article | Year |
|---|---|
[Gamma-vinyl GABA and tardive dyskinesia: a single-blind study versus placebo].
Topics: 4-Aminobutyrate Transaminase; Adolescent; Adult; Aged; Aminocaproates; Drug Evaluation; Dyskinesia, | 1984 |
1 other study available for vigabatrin and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Effect of gamma-vinyl GABA in tardive dyskinesia.
Topics: Adult; Aged; Aminocaproates; Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Male; Middle Ag | 1983 |